Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia

Drug and Alcohol Review

Volumn 32, Issue 5, 2013, Pages 468-474

  Degenhardt, Louisa ^a,b   Gilmour, Stuart ^c   Shand, Fiona ^a   Bruno, Raimondo ^d   Campbell, Gabrielle ^a   Mattick, Richard P ^a   Larance, Briony ^a   Hall, Wayne ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TASMANIA   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Chronic pain; Heroin; Injecting drug use; Opioid substitution therapy; Pharmaceutical opioid

Indexed keywords

DIAMORPHINE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; CHRONIC PAIN; DRUG MISUSE; FEMALE; HUMAN; INJECTING DRUG USE; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; PHARMACEUTICAL OPIOID; SUBSTANCE ABUSE; YOUNG ADULT;

CHRONIC PAIN; HEROIN; INJECTING DRUG USE; OPIOID SUBSTITUTION THERAPY; PHARMACEUTICAL OPIOID;

ADULT; AGED; ANALGESICS, OPIOID; AUSTRALIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; PRESCRIPTION DRUG MISUSE; QUEENSLAND; SUBSTANCE ABUSE, INTRAVENOUS; TASMANIA; VICTORIA; YOUNG ADULT;

EID: 84884714106     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12066     Document Type: Article

References (22)

1. Dhalla IA, Persaud N, Juurlink DN. Facing up to the prescription opioid crisis. BMJ 2011;343: doi: 10.1136/bmj.d5142.
2. Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust 2011;195:280-284.
3. Rintoul AC, Dobbin MDH, Drummer OH, Ozanne-Smith J. Increasing deaths involving oxycodone, Victoria, Australia, 2000-09. Inj Prev 2011;17:254-259.
4. Degenhardt L, Black E, Breen C, etal. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev 2006;25:403-412.
5. Degenhardt L, Larance B, Mathers B, etal. Benefits and risks of pharmaceutical opioids: essential treatment and diverted medication. A global review of availability, extramedical use, injection and the association with HIV. Sydney: University of New South Wales, 2008.
6. Day C, Degenhardt L, Hall W. Changes in the initiation of heroin use after a reduction in heroin supply. Drug and Alcohol Review. 2006;25(4):307-313.
7. Stafford J, Burns L. Australia drug trends 2010: findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No. 55. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2011.
8. Australian Government Department of Health and Ageing. Australian Statistics on Medicine 2009. Canberra: Australian Government Department of Health and Ageing, 2009: Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/913697554D938FFDCA257967007A83EA/$File/ASM%202009.pdf (accessed May 2012).
9. Australian Government Department of Health and Ageing. 2009. Australian Statistics on Medicine. Canberra: Australian Government Department of Health and Ageing. Available at: http://www.pbs.gov.au/info/browse/statistics Accessed July 22nd 2013.
10. World Health Organization. Guidelines for ATC classification and DDD assignment 2011. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2011.
11. National Drug and Alcohol Research Centre: University of New South Wales. Illicit Drug Reporting System. Sydney, Australia Available at: http://ndarc.med.unsw.edu.au/project/illicit-drug-reporting-system-idrs. Accessed on July 22nd 2013 (accessed July 2012) 2012.
12. Kirby Institute. Australian NSP survey national data report 2002-2010. Sydney: Kirby Institute, University of New South Wales, 2010.
13. Day C, Conroy E, Lowe J, Page J, Dolan K. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users. Aust J Rural Health 2006;14:120-125.
14. O'Brien S, Black E, Degenhardt L, etal. AUSTRALIAN DRUG TRENDS 2006 findings from the Illicit Drug Reporting System (IDRS) NDARC monograph No. 60. Sydney: University of New South Wales, 2007.
15. Razali K, Thein HH, Bell J, etal. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend 2007;91:228-235.
16. Stafford J, Burns L. AUSTRALIAN DRUG TRENDS 2010 findings from the Illicit Drug Reporting System (IDRS) Australian Drug Trends Series No. 55. Sydney: National Drug and Alcohol Research Centre, 2011.
17. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J 2006;174:1589-1594.
18. Darke S, Duflou J, Torok M. Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008*. J Forensic Sci 2011;56:690-693.
19. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005;6:107-112.
20. Darke S. The life of the heroin user: typical beginnings, trajectories and outcomes. Cambridge: Cambridge University Press, 2011.
21. World Health Ogranization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: WHO Press, 2009.
22. Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD002208. DOI: 10.1002/14651858.CD002208.